drugset / Trial / NCT04945499
The Application of Glucose CEST MR Imaging in Brain Tumor
NaSingle-groupOpen-labelDiagnostic
Summary
Recently, natural D-glucose was suggested as a potential biodegradable contrast agent. The feasibility of using D-glucose for dynamic perfusion imaging was explored to detect malignant brain tumors based on blood brain barrier breakdown. Our study try to evaluate the feasibility of dynamic glucose enhanced(DGE) magnetic resonance imaging（MRI）in brain tumor, which based on D-glucose weighted chemical exchange saturation transfer (gluceoCEST).
Timeline
- Start
- 2019-06-01
- Primary completion
- 2022-06-30
- Completion
- 2023-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dextrose | Unknown | 25 g | Intravenous |
Indications
No indication recorded.